BENIFITS OF DEXMEDETOMIDINE To DECREASE URINARY CATHETER RELATED DISCOMFORT IN PATIENTS UNDERGOING OPERATION FOR URINARY BLADDER TUMOR.
Not Applicable
- Conditions
- Health Condition 1: C672- Malignant neoplasm of lateral wallof bladder
- Registration Number
- CTRI/2019/05/019458
- Lead Sponsor
- none
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 ASA-1&2
2 Patients undergoing elective TURBT under general anaesthesia
Exclusion Criteria
1 Female patients
2 Patients undergoing emergency surgery
3 Refusal by the patients
4 Patients with bladder outflow obstruction or overactive bladder (frequency greater than three times per night or more than eight times per 24 h)
5 Patients having autonomic neuropathy
6 Patients with renal dysfunction (serum creatinine >1.6mg/dl)
7 Patients with neurogenic bladder
8 Heart failure and arrhythmia
9 Morbid obesity
10 Patient with hepatic dysfunction
11 Known allergy to the study drug
12 Patient affected with any psychiatric illness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method